SCHEMBL22983967

SCHEMBL22983967

Cc1cn([C@H]2C[C@H]3O[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)OC[C@@H]3O2)c(=O)nc1NC(=O)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.37
▸ RIN1 Q13671 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ RNASE1 P07998 1/20 0.33
▸ NT5M Q9NPB1 1/20 0.32
▸ P2RY6 Q15077 3/20 0.32
▸ P2RY14 Q15391 2/20 0.32
▸ NT5E P21589 1/20 0.32
▸ ADORA3 P0DMS8 3/20 0.31
▸ ADORA1 P30542 2/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ P2RX3 P56373 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21886706 0.81 ABL1 (0.33) ABL1RIN1POLBRNASE1
SCHEMBL29674405 0.79 ADORA3 (0.40) ADORA3ADORA2AADORA2B
SCHEMBL22983976 0.79 ADORA3 (0.40) ADORA3ADORA2AADORA2B
SCHEMBL6893059 0.79 ADORA3 (0.39) NT5EADORA3ADORA1
SCHEMBL22577522 0.79 ADK (0.34) —
SCHEMBL25512274 0.76 POLB (0.42) ABL1RIN1POLBRNASE1P2RY6
SCHEMBL17832132 0.75 POLB (0.37) ABL1RIN1POLBP2RY6P2RY14
SCHEMBL22992440 0.74 ABL1 (0.42) ABL1RIN1POLBADORA3ADORA1
SCHEMBL14066105 0.73 ABL1 (0.33) ABL1RIN1P2RY6P2RY14NT5E
SCHEMBL22984030 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159922-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2023-05-25 — — US disclosed
US-20230159922-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2023-05-25 — — US disclosed
EP-4013428-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF Ionis Pharmaceuticals, Inc. (US) 2022-06-22 — — EP disclosed
WO-2021030763-A1 MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2021-02-18 — — WO disclosed
Send feedback